Literature DB >> 28066631

Serum uric acid levels and cardiovascular disease: the Gordian knot.

Efrén Martínez-Quintana1, Antonio Tugores2, Fayna Rodríguez-González3.   

Abstract

Hyperuricemia is defined as serum uric acid level of more than 7 mg/dL and blood levels of uric acid are causally associated with gout, as implicated by evidence from randomized clinical trials using urate lowering therapies. Uric acid as a cardiovascular risk factor often accompanies metabolic syndrome, hypertension, diabetes, dyslipidemia, chronic renal disease, and obesity. Despite the association of hyperuricemia with cardiovascular risk factors, it has remained controversial as to whether uric acid is an independent predictor of cardiovascular disease. To settle this issue, and in the absence of large randomized controlled trials, Mendelian randomization analysis in which the exposure is defined based on the presence or absence of a specific allele that influences a risk factor of interest have tried to shed light on this.

Entities:  

Keywords:  Hyperuricemia; cardiovascular risk factors; coronary artery disease; mendelian randomization

Year:  2016        PMID: 28066631      PMCID: PMC5179380          DOI: 10.21037/jtd.2016.11.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  41 in total

Review 1.  Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.

Authors:  Wolfram Doehner; Ulf Landmesser
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

2.  Mendelian randomization: present and future of epidemiological studies in cardiology.

Authors:  Ignacio Iturrieta-Zuazo; Stefan Walter
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2014-11-20

3.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

Review 4.  Serum uric acid and the risk of cardiovascular and renal disease.

Authors:  Claudio Borghi; Enrico Agabiti Rosei; Thomas Bardin; Jesse Dawson; Anna Dominiczak; Jan T Kielstein; Athanasios J Manolis; Fernando Perez-Ruiz; Giuseppe Mancia
Journal:  J Hypertens       Date:  2015-09       Impact factor: 4.844

Review 5.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

6.  Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.

Authors:  Awsan Noman; Donald S C Ang; Simon Ogston; Chim C Lang; Allan D Struthers
Journal:  Lancet       Date:  2010-06-09       Impact factor: 79.321

Review 7.  Febuxostat for treating chronic gout.

Authors:  Jean H Tayar; Maria Angeles Lopez-Olivo; Maria E Suarez-Almazor
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

8.  Metabolic basis for disorders of purine nucleotide degradation.

Authors:  I H Fox
Journal:  Metabolism       Date:  1981-06       Impact factor: 8.694

9.  Association between serum uric acid and development of type 2 diabetes.

Authors:  Satoru Kodama; Kazumi Saito; Yoko Yachi; Mihoko Asumi; Ayumi Sugawara; Kumiko Totsuka; Aki Saito; Hirohito Sone
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

10.  Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.

Authors:  Tanya Keenan; Wei Zhao; Asif Rasheed; Weang K Ho; Rainer Malik; Janine F Felix; Robin Young; Nabi Shah; Maria Samuel; Nasir Sheikh; Megan L Mucksavage; Omar Shah; Jin Li; Michael Morley; Annika Laser; Nadeem Hayat Mallick; Khan Shah Zaman; Mohammad Ishaq; Syed Zahed Rasheed; Fazal-Ur-Rehman Memon; Faisal Ahmed; Bashir Hanif; Muhammad Shakir Lakhani; Muhammad Fahim; Madiha Ishaq; Naresh Kumar Shardha; Naveeduddin Ahmed; Khalid Mahmood; Waseem Iqbal; Saba Akhtar; Rabia Raheel; Christopher J O'Donnell; Christian Hengstenberg; Winifred März; Sekar Kathiresan; Nilesh Samani; Anuj Goel; Jemma C Hopewell; John Chambers; Yu-Ching Cheng; Pankaj Sharma; Qiong Yang; Jonathan Rosand; Giorgio B Boncoraglio; Shahana Urooj Kazmi; Hakon Hakonarson; Anna Köttgen; Andreas Kalogeropoulos; Philippe Frossard; Ayeesha Kamal; Martin Dichgans; Thomas Cappola; Muredach P Reilly; John Danesh; Daniel J Rader; Benjamin F Voight; Danish Saleheen
Journal:  J Am Coll Cardiol       Date:  2016-02-02       Impact factor: 24.094

View more
  6 in total

1.  The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components.

Authors:  Mahantesh I Biradar; Kuang-Mao Chiang; Hsin-Chou Yang; Yen-Tsung Huang; Wen-Harn Pan
Journal:  Int J Obes (Lond)       Date:  2019-11-21       Impact factor: 5.095

2.  Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice.

Authors:  Ruixia Bao; Mengyang Liu; Dan Wang; Shaoshi Wen; Haiyang Yu; Yi Zhong; Zheng Li; Yi Zhang; Tao Wang
Journal:  Front Pharmacol       Date:  2019-12-10       Impact factor: 5.810

3.  Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults.

Authors:  Juan Manuel Vargas-Morales; Martha Guevara-Cruz; Celia Aradillas-García; Lilia G Noriega; Armando Tovar; Jorge Alejandro Alegría-Torres
Journal:  F1000Res       Date:  2021-03-17

Review 4.  Recent advances on uric acid transporters.

Authors:  Liuqing Xu; Yingfeng Shi; Shougang Zhuang; Na Liu
Journal:  Oncotarget       Date:  2017-08-10

5.  Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice.

Authors:  Zhizhen Qin; Shoubao Wang; Yihuang Lin; Ying Zhao; Shengqian Yang; Junke Song; Tao Xie; Jinlong Tian; Song Wu; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2017-07-29       Impact factor: 11.413

6.  Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana.

Authors:  Ellen Gobusamang; Naledi G Nyepetsi; Modisa S Motswaledi; Ishmael Kasvosve
Journal:  Afr J Lab Med       Date:  2019-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.